Abstract:BackgroundGenome-wide association (GWA) using large numbers of single nucleotide polymorphisms (SNPs) is now a powerful, state-of-the-art approach to mapping human disease genes. When a GWA study detects association between a SNP and the disease, this signal usually represents association with a set of several highly correlated SNPs in strong linkage disequilibrium. The challenge we address is to distinguish among these correlated loci to highlight potential functional variants and prioritize them for follow-up.ResultsWe implemented a systematic method for testing association across diverse population samples having differing histories and LD patterns, using a logistic regression framework. The hypothesis is that important underlying biological mechanisms are shared across human populations, and we can filter correlated variants by testing for heterogeneity of genetic effects in different population samples. This approach formalizes the descriptive comparison of p-values that has typified similar cross-population fine-mapping studies to date. We applied this method to correlated SNPs in the cholinergic nicotinic receptor gene cluster CHRNA5-CHRNA3-CHRNB4, in a case-control study of cocaine dependence composed of 504 European-American and 583 African-American samples. Of the 10 SNPs genotyped in the r2 ≥ 0.8 bin for rs16969968, three demonstrated significant cross-population heterogeneity and are filtered from priority follow-up; the remaining SNPs include rs16969968 (heterogeneity p = 0.75). Though the power to filter out rs16969968 is reduced due to the difference in allele frequency in the two groups, the results nevertheless focus attention on a smaller group of SNPs that includes the non-synonymous SNP rs16969968, which retains a similar effect size (odds ratio) across both population samples.ConclusionFiltering out SNPs that demonstrate cross-population heterogeneity enriches for variants more likely to be important and causative. Our approach provides an important and effective tool to help interpret results from the many GWA studies now underway.

Exploiting pleiotropy to enhance variant discovery with functional false discovery rates

Controlling the Rate of GWAS False Discoveries

Leveraging polygenic functional enrichment to improve GWAS power

Principles for the Post-Gwas Functional Characterisation of Risk Loci

SEMI-PARAMETRIC COVARIATE-MODULATED LOCAL FALSE DISCOVERY RATE FOR GENOME-WIDE ASSOCIATION STUDIES

Simultaneous detection of novel genes and SNPs by adaptive p-value combination

Controlling the joint local false discovery rate is more powerful than meta-analysis methods in joint analysis of summary statistics from multiple genome-wide association studies

FUSE: Improving the estimation and imputation of variant impacts in functional screening

Funmap: integrating high-dimensional functional annotations to improve fine-mapping

Revisiting the genome-wide significance threshold for common variant GWAS

Genome-wide fine-mapping improves identification of causal variants

In search of causal variants: refining disease association signals using cross-population contrasts

Improved detection of common variants in coronary artery disease and blood pressure using a pleiotropy cFDR method

HAPRAP: a haplotype-based iterative method for statistical fine mapping using GWAS summary statistics

Enhanced Genetic Analysis of Type 1 Diabetes by Selecting Variants on Both Effect Size and Significance, and by Integration with Autoimmune Thyroid Disease

2dFDR: a new approach to confounder adjustment substantially increases detection power in omics association studies

Accurate cross-platform GWAS analysis via two-stage imputation

A dynamic model for genome-wide association studies

Causal considerations can determine the utility of machine learning assisted GWAS

Weak Signal Inclusion under Dependence and Applications in Genome-wide Association Study

Synthetic surrogates improve power for genome-wide association studies of partially missing phenotypes in population biobanks